e-learning
resources
Courses
2013
Login
Search all ERS
e-learning
resources
COVID-19
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
Global Lung Function Initiative
e-learning
Case reports
CME Online
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
VALUE-Dx
Courses and events
COVID-19
Disease Areas
Events
Publications
Guidelines
e-learning
VALUE-Dx
Login
Search
Monitoring of asthma, COPD and other airway diseases
Target audience
Pulmonologists
Trainees in pulmonology
Research fellows involved in research on airway inflammation/oxidative stress
Laboratory technicians performing lung function tests, methacholine challenge or exhaled breath tests
Educational aims
To provide the participants with a critical overview of different modes of monitoring airway diseases associated inflammation and oxidative stress in research and clinical practice.
To give participants methodological advice with information on the current guidelines in each method and technique.
To present the most important steps in using these techniques and determine the most frequent pitfalls when using them, together with potential data interpretation problems.
Download all media
Introduction
B. Balbi (Veruno, Italy)
How to value clinical presentation (symptom score, QoL questionnaires)
G. Joos (Ghent, Belgium)
Lung function measurements in adults and children
F. de Jongh (Enschedee, Netherlands)
Limitations of traditional tests, unanswered aspects of airway diseases
B. Balbi (Veruno, Italy)
Measurement of airway hyperresponsiveness; part I: direct challenges
E. Bel (Amsterdam, Netherlands)
Measurement of airway hyperresponsiveness; part II: indirect challenges
G. Joos (Ghent, Belgium)
Methodological considerations of sputum induction
R. Louis (Liège, Belgium)
Applications of induced sputum sampling in asthma and COPD
A. Spanevello (Tradate, Italy)
Special considerations in sputum induction in severe patients
E. Bel (Amsterdam, Netherlands)
Methods to measure exhaled and nasal nitric oxide
M. Corradi (Parma, Italy)
Methods to measure other exhaled volatiles (CO, ethane, pentane, etc…)
P. Paredi (London, UK)
Electronic noses- breathprints
P. J. Sterk (Amsterdam, The Netherlands)
Methods to collect exhaled breath condensate
I. Horváth (Budakeszi, Hungary)
Methods to measure different mediators in EBC
M. Corradi (Parma, Italy)
Monitoring of airway diseases in children
J. C. De Jongste (Rotterdam, The Netherlands)
Applications of exhaled and nasal nitric oxide in airway diseases
P.J. Barnes (London, United Kingdom)
Value of exhaled volatile organic compounds in monitoring airway disease
P. J. Sterk (Amsterdam, The Netherlands)
Markers of airway diseases in exhaled breath condensate and their clinical value
P.J. Barnes (London, United Kingdom)
Comparison of exhaled biomarkers to other markers of airway diseases
I. Horváth (Budakeszi, Hungary)
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept